Ali-Jackson Kamil bought RIGL
May 25, 2024 · Form 4 insider transaction
Ali-Jackson Kamil bought 30,000 shares of Rigel Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderAli-Jackson Kamil
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 25, 2024
Filing dateMay 29, 2024
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.